NEW DELHI (Reuters)—For nearly two years, Parkway Pantai has delayed the opening of its 450-bed India hospital, the Singapore-based medical firm’s bid to cash in on one of Asia’s fastest growing private healthcare markets, as it waited for the necessary permits. Parkway, a unit of the world’s second largest healthcare group by market value IHH…
Articles by Natasha Yetman
Pfizer Loses UK Patent Case over Use of Lyrica Drug for Pain
LONDON (Reuters)—Pfizer suffered a major setback in Britain on Thursday when the High Court in London ruled that claims of patent protection for the use of its $5 billion-a-year drug Lyrica as a pain treatment were invalid. Lyrica, known generically as pregabalin, was originally developed for epilepsy. However, further research showed it could also help patients…
Pacira Sues FDA over Pain Drug Marketing Restrictions
NEW YORK (Reuters)—Pacira Pharmaceuticals Inc. on Tuesday filed a lawsuit seeking a court order allowing it to promote its post-surgery pain drug, Exparel (bupivacaine liposome injectable suspension), for a wide range of surgeries, which the U.S. Food and Drug Administration opposes. The lawsuit, filed in federal court in Manhattan, cites another New York judge’s recent…
Electronic Health Records Software Often Written Without Doctors’ Input
(Reuters Health)—The reason why many doctors find electronic health records (EHR) difficult to use might be that the software wasn’t properly tested, researchers suggests. Current guidelines and industry standards suggest that new EHR software should be tested by at least 15 end users with a clinical background to make sure they are usable and safe…
Patients Steered to Fewer Pharmacies May Fill More Prescriptions
(Reuters Health)—When patients have drug benefits that encourage them to save money by using certain pharmacies, they may end up filling more prescriptions, a company-funded study suggests. Narrow pharmacy networks that cover prescriptions only at certain retailers and drug benefits that offer consumers lower out-of-pocket fees at a subset of preferred pharmacies have become more…
Regulatory Backlog in Emerging Nations Adding Years to Drug Approvals
BASEL (Reuters)—A regulatory backlog in developing countries including China has created wait times for drugs awaiting approval of up to seven years, Roche Holding AG Chief Executive Severin Schwan said on Tuesday. “Unfortunately, time lines are getting longer and longer in countries like China,” Schwan said at an oncology event at the Swiss company’s headquarters…
New Recommendations Support Effective Use of Telemedicine in Primary Care
NEW YORK (Reuters Health)—The American College of Physicians (ACP) has issued a baker’s dozen of recommendations intended to guide the effective use of telemedicine in primary care settings. “The recommendations balance the potential benefits and expanded use of telemedicine with the importance of maintaining the patient-physician relationship and patient safety,” Hilary Daniel from American College…
U.S. Doctors Group Says Planned Health Mergers Are Anti-Competitive
NEW YORK (Reuters)—Two proposed mergers of U.S. health insurers worth tens of billions of dollars would hurt competition in commercial health plans in as many as 17 states, the American Medical Association, the U.S. group that represents physicians, said on Tuesday. Aetna Inc. announced plans to buy smaller rival Humana Inc. in early July and…
Can Childhood Fitness Predict Adult Knee Problems or OA?
An Australian study found an association between child physical performance measures and adult knee structures. The data, collected from three points in participants’ lives, revealed a link between childhood activity and adult tibial cartilage volume and bone area.
Arthritis May Be Worse in Poor Countries, but Seem Worse in Rich Ones
(Reuters Health)—A study of people with rheumatoid arthritis (RA) finds that those in wealthy nations are more troubled by it, even though people in poor countries have more severe symptoms. The results, tallied from 17 countries, suggest that cultural factors may influence patients’ perception of their illness, and possibly even the results of clinical trials…
- « Previous Page
- 1
- …
- 85
- 86
- 87
- 88
- 89
- …
- 97
- Next Page »